{
  "id": "mhgap#referral_b980e4f7",
  "content": "If the first monotherapy is not successful for focal onset seizures, an alternative first-line\nmonotherapy should be tried.\nLacosamide should be offered as a second-line monotherapy for focal onset seizures if\nnone of the first-line medicines are effective.\nIf antiseizure medicine monotherapy is unsuccessful in people with generalized onset\nseizures or focal onset seizures, prompt referral should be made to a specialist for\nconsideration of other treatment options.\nStrong recommendation. High certainty of evidence.\nEPI4 (update) 4.1 The efficacy of antiseizure medicines (ASMs) is not thought to differ in males and females.\nAs such, this recommendation builds on EPI3 and focuses on the medicines that are now\nbeing preferentially recommended as therapeutic options.\nIn women and girls with epilepsy who are of childbearing potential, lamotrigine or\nlevetiracetam should be offered as first-line monotherapy for both generalized onset\nseizures and focal onset seizures.\nWomen with epilepsy should have seizures controlled as well as possible with the\nminimum dose of ASMs taken in monotherapy, wherever possible.\nValproic acid (sodium valproate) is not recommended in women and girls of childbearing\npotential because of potential harm to the fetus.\nStrong recommendation. Very low certainty of evidence.",
  "metadata": {
    "source": "WHO mhGAP-IG 2023",
    "url": "https://www.who.int/",
    "condition": "General",
    "risk_band": "low",
    "topics": [
      "study",
      "referral",
      "management"
    ],
    "is_clinical": true,
    "is_advice": false
  },
  "index_text": "General â€” Referral If the first monotherapy is not successful for focal onset seizures, an alternative first-line\nmonotherapy should be tried.\nLacosamide should be offered as a second-line monotherapy for focal onset seizures if\nnone of the first-line medicines are effective.\nIf antiseizure medicine monotherapy is unsuccessful in people with generalized onset\nseizures or focal onset seizures, prompt referral should be made to a specialist for\nconsideration of other treatment options.\nStrong recommendation. High certainty of evidence.\nEPI4 (update) 4.1 The efficacy of antiseizure medicines (ASMs) is not thought to differ in males and females.\nAs such, this recommendation builds on EPI3 and focuses on the medicines that are now\nbeing preferentially recommended as therapeutic options.\nIn women and girls with epilepsy who are of childbearing potential, lamotrigine or\nlevetiracetam should be offered as first-line monotherapy for both generalized onset\nseizures and focal onset seizures.\nWomen with epilepsy should have seizures controlled as well as possible with the\nminimum dose of ASMs taken in monotherapy, wherever possible.\nValproic acid (sodium valproate) is not recommended in women and girls of childbearing\npotential because of potential harm to the fetus.\nStrong recommendation. Very low certainty of evidence. If the first monotherapy is not successful for focal onset seizures, an alternative first-line\nmonotherapy should be tried. lacosamide should be offered as a second-line monotherapy for focal onset seizures if\nnone of th..."
}